HVTN 071

A phase IB clinical trial to define assays and methods to be used for evaluating potential correlates of immunity following administration of the Merck Adenovirus serotype 5 HIV-1 gag/pol/nef vaccine in healthy, HIV-1 uninfected adult participants

Trial Details:

Ib Terminated
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) July 13, 2007
MRKAd5 HIV-1 gag Adeno 5 gag B
MRKAd5 HIV-1 gag Viral Vector - Adeno
USA 60